PBX2 and neoplasm: The missense mutation of the PBX2 gene could contribute to tumor progression by controlling the gene regulatory networks involved in cell proliferation, apoptosis, cell cycle, epithelial-mesenchymal transition (EMT), invasion, and metastasis, as well as the stemness of cancer cells [42].